|
1
|
Sun S, Jiang Y, Wang R, Liu C, Liu X, Song
N, Guo Y, Guo R, Du L, Jiang S, et al: Treatment of
paraquat-induced lung injury with an anti-c5a antibody: Potential
clinical application. Crit Care Med. 46:e419–e425. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Han J, Ma D, Zhang M, Yang X and Tan D:
Natural antioxidant betanin protects rats from paraquat-induced
acute lung injury interstitial pneumonia. Biomed Res Int.
2015:6081742015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cai L, Yi F, Dai Z, Huang X, Zhao YD,
Mirza MK, Xu J, Vogel SM and Zhao YY: Loss of caveolin-1 and
adiponectin induces severe inflammatory lung injury following LPS
challenge through excessive oxidative/nitrative stress. Am J
Physiol Lung Cell Mol Physiol. 306:L566–L573. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sunil VR, Vayas KN, Cervelli JA, Malaviya
R, Hall L, Massa CB, Gow AJ, Laskin JD and Laskin DL:
Pentoxifylline attenuates nitrogen mustard-induced acute lung
injury, oxidative stress and inflammation. Exp Mol Pathol.
97:89–98. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Amirshahrokhi K: Anti-inflammatory effect
of thalidomide in paraquat-induced pulmonary injury in mice. Int
Immunopharmacol. 17:210–215. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yin Y, Guo X, Zhang SL and Sun CY:
Analysis of paraquat intoxication epidemic (2002–2011) within
China. Biomed Environ Sci. 26:509–512. 2013.PubMed/NCBI
|
|
7
|
Choi JS, Jou SS, Oh MH, Kim YH, Park MJ,
Gil HW, Song HY and Hong SY: The dose of cyclophosphamide for
treating paraquat-induced rat lung injury. Korean J Intern Med.
28:420–427. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu MW, Su MX, Zhang W, Wang YQ, Chen M,
Wang L and Qian CY: Protective effect of Xuebijing injection on
paraquat-induced pulmonary injury via down-regulating the
expression of p38 MAPK in rats. BMC Complement Altern Med.
14:4982014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li Y, Cao Y, Zeng Z, Liang M, Xue Y, Xi C,
Zhou M and Jiang W: Angiotensin-converting enzyme
2/angiotensin-(1–7)/Mas axis prevents lipopolysaccharide-induced
apoptosis of pulmonary microvascular endothelial cells by
inhibiting JNK/NF-κB pathways. Sci Rep. 5:82092015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chou CH, Chuang LY, Lu CY and Guh JY:
Interaction between TGF-β and ACE2-Ang-(1–7)-Mas pathway in high
glucose-cultured NRK-52E cells. Mol Cell Endocrinol. 366:21–30.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
de Man FS, Tu L, Handoko ML, Rain S,
Ruiter G, François C, Schalij I, Dorfmüller P, Simonneau G, Fadel
E, et al: Dysregulated renin-angiotensin-aldosterone system
contributes to pulmonary arterial hypertension. Am J Respir Crit
Care Med. 186:780–789. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Song B, Zhang ZZ, Zhong JC, Yu XY, Oudit
GY, Jin HY, Lu L, Xu YL, Kassiri Z, Shen WF, et al: Loss of
angiotensin-converting enzyme 2 exacerbates myocardial injury via
activation of the CTGF-fractalkine signaling pathway. Circ J.
77:2997–3006. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tipnis SR, Hooper NM, Hyde R, Karran E,
Christie G and Turner AJ: A human homolog of angiotensin-converting
enzyme. Cloning and functional expression as a
captopril-insensitive carboxypeptidase. J Biol Chem.
275:33238–33243. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li G, Yuzhen L, Yi C, Xiaoxiang C, Wei Z,
Changqing Z and Shuang Y: DNaseI protects against Paraquat-induced
acute lung injury and pulmonary fibrosis mediated by mitochondrial
DNA. Biomed Res Int. 2015:3869522015.PubMed/NCBI
|
|
15
|
Wu H, Li Y, Wang Y, Xu D, Li C, Liu M, Sun
X and Li Z: Tanshinone IIA attenuates bleomycin-induced pulmonary
fibrosis via modulating angiotensin-converting enzyme
2/angiotensin-(1–7) axis in rats. Int J Med Sci. 11:578–586. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan
B, Yang P, Sarao R, Wada T, Leong-Poi H, et al:
Angiotensin-converting enzyme 2 protects from severe acute lung
failure. Nature. 436:112–116. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu M, Cao F, Liu L, Zhang B, Wang Y, Dong
H, Cui Y, Dong M, Xu D, Liu Y, et al: Tanshinone IIA-induced
attenuation of lung injury in endotoxemic mice is associated with
reduction of hypoxia-inducible factor 1α expression. Am J Respir
Cell Mol Biol. 45:1028–1035. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu M, Dong MQ, Cao FL, Liu ML, Wang YX,
Dong HY, Huang YF, Liu Y, Wang XB, Zhang B, et al: Tanshinone IIA
reduces lethality and acute lung injury in LPS-treated mice by
inhibition of PLA2 activity. Eur J Pharmacol. 607:194–200. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
National Council for Science and
Technology: Regulations on the Management of Experimental Animals.
State Council Bulletin. 2017.1 Supplement:(Chinese).
|
|
20
|
Adam M, Meyer S, Knors H, Klinke A,
Radunski UK, Rudolph TK, Rudolph V, Spin JM, Tsao PS,
Costard-Jäckle A and Baldus S: Levosimendan displays
anti-inflammatory effects and decreases MPO bioavailability in
patients with severe heart failure. Sci Rep. 5:97042015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ollivett TL, Caswell JL, Nydam DV,
Duffield T, Leslie KE, Hewson J and Kelton D: Thoracic
ultrasonography and bronchoalveolar lavage fluid analysis in
holstein calves with subclinical lung lesions. J Vet Intern Med.
29:1728–1734. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ede LC, O'Brien J, Chonmaitree T, Han Y
and Patel JA: Lactate dehydrogenase as a marker of nasopharyngeal
inflammatory injury during viral upper respiratory infection:
Implications for acute otitis media. Pediatr Res. 73:349–354. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tomita M, Okuyama T, Katsuyama H, Miura Y,
Nishimura Y, Hidaka K, Otsuki T and Ishikawa T: Mouse model of
paraquat-poisoned lungs and its gene expression profile.
Toxicology. 231:200–209. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu Z, Zhao H, Liu W, Li T, Wang Y and
Zhao M: NLRP3 inflammasome activation is essential for
paraquat-induced acute lung injury. Inflammation. 38:433–444. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu S, Liu K, Sun Q, Liu W, Xu W, Denoble
P, Tao H and Sun X: Consumption of hydrogen water reduces
paraquat-induced acute lung injury in rats. J Biomed Biotechnol.
2011:3050862011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Novaes RD, Gonçalves RV, Cupertino MC,
Marques DC, Rosa DD, Mdo Peluzio C, Neves CA and Leite JP: Bark
extract of Bathysa cuspidata attenuates extra-pulmonary acute lung
injury induced by paraquat and reduces mortality in rats. Int J Exp
Pathol. 93:225–233. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
He F, Xu P, Zhang J, Zhang Q, Gu S, Liu Y
and Wang J: Efficacy and safety of pulse immunosuppressive therapy
with glucocorticoid and cyclophosphamide in patients with paraquat
poisoning: A meta-analysis. Int Immunopharmacol. 27:1–7. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li J, Xu M, Fan Q, Xie X, Zhang Y, Mu D,
Zhao P, Zhang B, Cao F, Wang Y, et al: Tanshinone IIA ameliorates
seawater exposure-induced lung injury by inhibiting aquaporins
(AQP) 1 and AQP5 expression in lung. Respir Physiol Neurobiol.
176:39–49. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li JH, Xu M, Xie XY, Fan QX, Mu DG, Zhang
Y, Cao FL, Wang YX, Zhao PT, Zhang B, et al: Tanshinone IIA
suppresses lung injury and apoptosis, and modulates protein kinase
B and extracellular signal-regulated protein kinase pathways in
rats challenged with seawater exposure. Clin Exp Pharmacol Physiol.
38:269–277. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xie XY, Zhang B, Li JH, Fan QX, Zhang Y,
Mu DG, Li WP, Xu M, Zhao PT, Jin FG and Li ZC: Sodium tanshinone
iia sulfonate attenuates seawater aspiration-induced acute
pulmonary edema by up-regulating Na(+),K(+)-ATPase activity. Exp
Lung Res. 37:482–491. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang Y, Zhang B, Xu DQ, Li WP, Xu M, Li
JH, Xie XY, Fan QX, Liu W, Mu DG, et al: Tanshinone IIA attenuates
seawater aspiration-induced lung injury by inhibiting macrophage
migration inhibitory factor. Biol Pharm Bull. 34:1052–1057. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang J, Dong MQ, Liu ML, Xu DQ, Luo Y,
Zhang B, Liu LL, Xu M, Zhao PT, Gao YQ and Li ZC: Tanshinone IIA
modulates pulmonary vascular response to agonist and hypoxia
primarily via inhibiting Ca2+ influx and release in normal and
hypoxic pulmonary hypertension rats. Eur J Pharmacol. 640:129–138.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lin JL, Lin-Tan DT, Chen KH and Huang WH:
Repeated pulse of methylprednisolone and cyclophosphamide with
continuous dexamethasone therapy for patients with severe paraquat
poisoning. Crit Care Med. 34:368–373. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang X, Yang J, Yu X, Cheng S, Gan H and
Xia Y: Angiotensin II-induced early and late inflammatory responses
through NOXs and MAPK pathways. Inflammation. 40:154–165. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhong J, Basu R, Guo D, Chow FL, Byrns S,
Schuster M, Loibner H, Wang XH, Penninger JM, Kassiri Z and Oudit
GY: Angiotensin-converting enzyme 2 suppresses pathological
hypertrophy, myocardial fibrosis, and cardiac dysfunction.
Circulation. 122:717–728. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen Q, Yang Y, Huang Y, Pan C, Liu L and
Qiu H: Angiotensin-(1–7) attenuates lung fibrosis by way of Mas
receptor in acute lung injury. J Surg Res. 185:740–747. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lubel JS, Herath CB, Tchongue J, Grace J,
Jia Z, Spencer K, Casley D, Crowley P, Sievert W, Burrell LM and
Angus PW: Angiotensin-(1–7), an alternative metabolite of the
renin-angiotensin system, is up-regulated in human liver disease
and has antifibrotic activity in the bile-duct-ligated rat. Clin
Sci (Lond). 117:375–386. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mercure C, Yogi A, Callera GE, Aranha AB,
Bader M, Ferreira AJ, Santos RA, Walther T, Touyz RM and
Reudelhuber TL: Angiotensin(1–7) blunts hypertensive cardiac
remodeling by a direct effect on the heart. Circ Res.
103:1319–1326. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Passos-Silva DG, Verano-Braga T and Santos
RA: Angiotensin-(1–7): Beyond the cardio-renal actions. Clin Sci
(Lond). 124:443–456. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan
B, Huan Y, Yang P, Zhang Y, Deng W, et al: A crucial role of
angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced
lung injury. Nat Med. 11:875–879. 2005. View Article : Google Scholar : PubMed/NCBI
|
